About ProHTA

Prospective Health Technology Assessment (ProHTA) is an interdisciplinary research project within the Cluster of Excellence for Medical Technology – Medical Valley European Metropolitan Region Nuremberg (EMN), which is funded by the German Federal Ministry of Education and Research (BMBF) in the period 2010 - 2014.

In order to assess the potential of medical technologies during the conceptual development phase, ProHTA combines the tools of public health, health technology assessment (HTA), epidemiology, mathematical decision modeling, economic evaluation and health informatics.

ProHTA provides a comprehensive methodological framework for the early assessment of emerging health technologies and personalized strategies in vascular diseases and cancer.

ProHTA’ s approach is fostering R&D of effective and efficient health technologies and therefore ensures sustainability in health care systems.